Variant report

Variant	nsv983180
Chromosome Location	chr11:33026769-33041930
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:524)
CpG islands
(count:732)
Chromatin interactive
region (count:23)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:524 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr11:33039311-33039873	HepG2	liver:	n/a	n/a
2	ARID3A	chr11:33040233-33040432	HepG2	liver:	n/a	n/a
3	ARID3A	chr11:33037131-33037894	HepG2	liver:	n/a	n/a
4	ARID3A	chr11:33040791-33040796	HepG2	liver:	n/a	n/a
5	ATF2	chr11:33033025-33033631	GM12878	blood:	n/a	n/a
6	ATF3	chr11:33037116-33037523	H1-hESC	embryonic stem cell:	n/a	chr11:33037392-33037401
7	ATF3	chr11:33037243-33037511	HepG2	liver:	n/a	chr11:33037392-33037401
8	ATF3	chr11:33037237-33037556	H1-hESC	embryonic stem cell:	n/a	chr11:33037392-33037401
9	ATF3	chr11:33037205-33037643	K562	blood:	n/a	chr11:33037392-33037401
10	BACH1	chr11:33037926-33038067	K562	blood:	n/a	n/a
11	BACH1	chr11:33037095-33037637	H1-hESC	embryonic stem cell:	n/a	n/a
12	BATF	chr11:33033447-33033795	GM12878	blood:	n/a	n/a
13	BATF	chr11:33032861-33033393	GM12878	blood:	n/a	n/a
14	BATF	chr11:33033446-33033786	GM12878	blood:	n/a	n/a
15	BATF	chr11:33033109-33033283	GM12878	blood:	n/a	n/a
16	BCL11A	chr11:33033092-33033386	GM12878	blood:	n/a	chr11:33033228-33033237
17	BHLHE40	chr11:33032957-33033383	GM12878	blood:	n/a	n/a
18	BHLHE40	chr11:33035416-33035695	HepG2	liver:	n/a	n/a
19	BHLHE40	chr11:33037132-33038103	HepG2	liver:	n/a	chr11:33037385-33037401
20	BHLHE40	chr11:33037275-33038051	GM12878	blood:	n/a	chr11:33037385-33037401
21	BHLHE40	chr11:33037160-33038448	K562	blood:	n/a	chr11:33037385-33037401
22	BRCA1	chr11:33033062-33033753	Hela-S3	cervix:	n/a	n/a
23	BRCA1	chr11:33035303-33035603	Hela-S3	cervix:	n/a	n/a
24	BRCA1	chr11:33037233-33037577	Hela-S3	cervix:	n/a	n/a
25	BRCA1	chr11:33037857-33039341	Hela-S3	cervix:	n/a	n/a
26	CBX3	chr11:33037124-33037471	K562	blood:	n/a	n/a
27	CBX3	chr11:33037082-33037645	K562	blood:	n/a	n/a
28	CCNT2	chr11:33037140-33038022	K562	blood:	n/a	chr11:33037392-33037401
29	CEBPB	chr11:33035258-33035607	A549	lung:	n/a	chr11:33035417-33035428 chr11:33035415-33035426 chr11:33035415-33035428 chr11:33035415-33035428
30	CEBPB	chr11:33037208-33037610	Hela-S3	cervix:	n/a	n/a
31	CEBPB	chr11:33035240-33035599	HepG2	liver:	n/a	chr11:33035417-33035428 chr11:33035415-33035426 chr11:33035415-33035428 chr11:33035415-33035428
32	CEBPB	chr11:33039554-33039904	HepG2	liver:	n/a	n/a
33	CEBPB	chr11:33035250-33035581	IMR90	lung:	n/a	chr11:33035415-33035428 chr11:33035415-33035426 chr11:33035415-33035428 chr11:33035417-33035428
34	CEBPB	chr11:33037222-33037417	H1-hESC	embryonic stem cell:	n/a	n/a
35	CEBPB	chr11:33040428-33040688	HepG2	liver:	n/a	chr11:33040525-33040536
36	CEBPB	chr11:33033107-33033479	IMR90	lung:	n/a	n/a
37	CEBPB	chr11:33035289-33035527	K562	blood:	n/a	chr11:33035417-33035428 chr11:33035415-33035426 chr11:33035415-33035428 chr11:33035415-33035428
38	CEBPB	chr11:33032920-33033826	Hela-S3	cervix:	n/a	n/a
39	CEBPB	chr11:33035211-33035696	Hela-S3	cervix:	n/a	chr11:33035417-33035428 chr11:33035415-33035426 chr11:33035415-33035428 chr11:33035415-33035428
40	CEBPB	chr11:33037194-33037417	HepG2	liver:	n/a	n/a
41	CEBPB	chr11:33035165-33035686	A549	lung:	n/a	chr11:33035417-33035428 chr11:33035415-33035426 chr11:33035415-33035428 chr11:33035415-33035428
42	CEBPD	chr11:33037046-33037619	HepG2	liver:	n/a	n/a
43	CEBPD	chr11:33037175-33037383	HepG2	liver:	n/a	n/a
44	CHD1	chr11:33038615-33038747	H1-hESC	embryonic stem cell:	n/a	n/a
45	CHD2	chr11:33037135-33038079	Hela-S3	cervix:	n/a	n/a
46	CHD2	chr11:33037140-33037505	HepG2	liver:	n/a	n/a
47	CHD2	chr11:33037890-33037894	K562	blood:	n/a	n/a
48	CHD2	chr11:33037256-33037994	H1-hESC	embryonic stem cell:	n/a	n/a
49	CHD2	chr11:33037767-33038101	HepG2	liver:	n/a	n/a
50	CHD2	chr11:33038356-33038434	HepG2	liver:	n/a	n/a

(count:732 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:33037542-33037592	HIPEpiC	eye:	n/a
2	chr11:33037542-33037592	HCPEpiC	choroid plexus:	n/a
3	chr11:33033607-33033657	GM12892	blood:	n/a
4	chr11:33036664-33036714	BE2_C	brain:	n/a
5	chr11:33033607-33033657	NB4	blood:	n/a
6	chr11:33037624-33037674	HCPEpiC	choroid plexus:	n/a
7	chr11:33037397-33037447	ProgFib	skin:	n/a
8	chr11:33037792-33037842	ovcar-3	ovarian:	n/a
9	chr11:33037792-33037842	Jurkat	blood:	n/a
10	chr11:33037792-33037842	HMEC	breast:	n/a
11	chr11:33037916-33037966	GM19239	blood:	n/a
12	chr11:33037626-33037676	NB4	blood:	n/a
13	chr11:33037626-33037676	PFSK-1	brain:	n/a
14	chr11:33037397-33037447	AG04449	skin:	fetal
15	chr11:33037397-33037447	MCF-7	breast:	n/a
16	chr11:33037792-33037842	AG04449	skin:	fetal
17	chr11:33037530-33037580	GM12878	blood:	n/a
18	chr11:33037542-33037592	HEEpiC	esophagus:	n/a
19	chr11:33033607-33033657	Hela-S3	cervix:	n/a
20	chr11:33037624-33037674	AG04450	lung:	fetal
21	chr11:33037916-33037966	CMK	blood:	n/a
22	chr11:33037542-33037592	GM12891	blood:	n/a
23	chr11:33037530-33037580	SK-N-MC	brain:	n/a
24	chr11:33037792-33037842	NHDF-neo	bronchial:	n/a
25	chr11:33036574-33036624	NT2-D1	testis:	n/a
26	chr11:33037916-33037966	PrEC	prostate:	n/a
27	chr11:33033607-33033657	Caco-2	colon:	n/a
28	chr11:33037916-33037966	H1-hESC	embryonic stem cell:	embryo
29	chr11:33036664-33036714	LNCaP	prostate:	n/a
30	chr11:33037626-33037676	GM12878	blood:	n/a
31	chr11:33037530-33037580	AG09319	gingival:	n/a
32	chr11:33037916-33037966	GM12891	blood:	n/a
33	chr11:33037792-33037842	GM12892	blood:	n/a
34	chr11:33037792-33037842	HAEpiC	amniotic membrane:	n/a
35	chr11:33037530-33037580	AG04450	lung:	fetal
36	chr11:33037542-33037592	NT2-D1	testis:	n/a
37	chr11:33036664-33036714	MCF-7	breast:	n/a
38	chr11:33037624-33037674	HCM	heart:	n/a
39	chr11:33036664-33036714	GM12892	blood:	n/a
40	chr11:33036664-33036714	H1-hESC	embryonic stem cell:	embryo
41	chr11:33037624-33037674	HCF	heart:	n/a
42	chr11:33037530-33037580	NHDF-neo	bronchial:	n/a
43	chr11:33033607-33033657	K562	blood:	n/a
44	chr11:33033607-33033657	NHBE	bronchial:	n/a
45	chr11:33037542-33037592	AG09319	gingival:	n/a
46	chr11:33036574-33036624	K562	blood:	n/a
47	chr11:33033607-33033657	AG09309	skin:	n/a
48	chr11:33036664-33036714	HEEpiC	esophagus:	n/a
49	chr11:33037397-33037447	HAEpiC	amniotic membrane:	n/a
50	chr11:33037397-33037447	HCT-116	colon:	n/a

(count:23 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:33035321..33039472-chr11:33059106..33064085,11	K562	blood:
2	chr11:33035440..33037281-chr11:33038611..33040663,2	K562	blood:
3	chr11:33035440..33037281-chr11:33038611..33040663,2	K562	blood:
4	chr11:33026998..33029027-chr11:33030665..33033114,2	K562	blood:
5	chr11:33040431..33043314-chr11:33047289..33049543,3	K562	blood:
6	chr11:33032509..33034576-chr11:33039239..33041376,2	MCF-7	breast:
7	chr11:33032509..33034576-chr11:33039239..33041376,2	MCF-7	breast:
8	chr11:33028329..33030227-chr11:33059191..33062094,2	MCF-7	breast:
9	chr11:33024197..33025927-chr11:33034012..33036342,2	K562	blood:
10	chr11:33037402..33038032-chr3:194304217..194304847,2	Hela-S3	cervix:
11	chr11:33031621..33033657-chr11:33034737..33037434,2	K562	blood:
12	chr11:33026998..33029027-chr11:33030665..33033114,2	K562	blood:
13	chr11:33038166..33041060-chr11:33046643..33049387,2	MCF-7	breast:
14	chr11:33041861..33044073-chr11:33051404..33053946,2	K562	blood:
15	chr11:33040311..33043058-chr11:33088314..33090844,2	K562	blood:
16	chr11:33036501..33039297-chr11:33041547..33045003,7	K562	blood:
17	chr11:33036802..33037655-chr5:61699205..61699998,2	Hela-S3	cervix:
18	chr11:33028555..33030770-chr11:33037403..33039211,2	K562	blood:
19	chr11:33033569..33035626-chr11:33052548..33054662,2	K562	blood:
20	chr11:33037810..33039404-chr11:33046604..33049179,2	K562	blood:
21	chr11:33035752..33039107-chr11:33059295..33062622,5	K562	blood:
22	chr11:33025764..33027601-chr11:33030519..33032926,2	K562	blood:
23	chr11:32912742..32915744-chr11:33035300..33038153,5	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CSTF3-1	chr11:33036823-33036899	NONHSAT018681

No data

Variant related genes	Relation type
DEPDC7	TF binding region
ENSG00000200615	TF binding region
DEPDC7	CpG island
ENSG00000200615	CpG island
ENSG00000060749	chromatin interactions
ENSG00000231770	chromatin interactions
ENSG00000176148	chromatin interactions
ENSG00000121690	chromatin interactions
ENSG00000200615	chromatin interactions
ENSG00000086200	chromatin interactions
ENSG00000086189	chromatin interactions

Extended variants
information (count: 527 )
Associated
traits (count: 80 )

Variant overlapped rSNPs/rCNVs (count:527 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs181844012	chr11:33026790-33026791	Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs563607731	chr11:33026801-33026802	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs563441850	chr11:33026828-33026829	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs532461320	chr11:33026861-33026862	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs112015987	chr11:33026952-33026953	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs546048693	chr11:33026966-33026967	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs559493001	chr11:33026978-33026979	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs186499097	chr11:33027005-33027006	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs548435511	chr11:33027020-33027021	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs568213296	chr11:33027060-33027061	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs73476646	chr11:33027062-33027063	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs146081644	chr11:33027070-33027071	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs551602622	chr11:33027138-33027139	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs570679109	chr11:33027224-33027225	Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs146463265	chr11:33027247-33027248	Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs539767245	chr11:33027251-33027252	Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs374005921	chr11:33027274-33027275	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs12290358	chr11:33027290-33027291	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs34647228	chr11:33027299-33027300	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs565579239	chr11:33027300-33027301	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs534608244	chr11:33027334-33027335	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs553449812	chr11:33027476-33027477	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs554395886	chr11:33027477-33027478	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs191432795	chr11:33027515-33027516	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs12283630	chr11:33027516-33027517	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs557214087	chr11:33027530-33027531	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs377564559	chr11:33027531-33027532	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs182023651	chr11:33027540-33027541	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs12283528	chr11:33027542-33027543	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs559590920	chr11:33027588-33027589	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs528525971	chr11:33027645-33027646	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs201892595	chr11:33027648-33027649	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs186174970	chr11:33027726-33027727	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs553749357	chr11:33027752-33027753	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs151217273	chr11:33027776-33027777	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs202173593	chr11:33027858-33027859	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs561881343	chr11:33027859-33027860	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs200372954	chr11:33027922-33027923	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs12270482	chr11:33027944-33027945	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs564344250	chr11:33027959-33027960	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs191417389	chr11:33027972-33027973	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs547023146	chr11:33027998-33027999	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs140406685	chr11:33028012-33028013	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs183194185	chr11:33028064-33028065	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs548181671	chr11:33028080-33028081	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs568032482	chr11:33028083-33028084	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs186610068	chr11:33028084-33028085	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs115291820	chr11:33028123-33028124	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs35121237	chr11:33028141-33028142	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs577151537	chr11:33028200-33028201	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:80)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Thyroid cancer	19087340	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Parathyroid adenoma	22454399	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastric cancer	17908304	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
Medulloblastoma	16783165	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18194544	CNVD
Potocki-Shaffer syndrome	19222835	CNVD
WAGR syndrome	19222835	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Breast cancer	21364760	CNVD
Glioblastoma multiforme	22286061	CNVD
Aniridia syndrome	21572526	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Retinoblastoma	22278416	CNVD
Denys-drash syndrome	21085971	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
WAGR syndrome	16773131	CNVD
Disorders of sex development	22290220	CNVD
Aniridia syndrome	17204608	CNVD
Mental retardation	17204608	CNVD
WAGR syndrome	19617690	CNVD
genitourinary abnormalities	17204608	CNVD
Breast cancer	16397240	CNVD
Mental retardation	16773131	CNVD
Multiple myeloma	16616336	CNVD
Cancer	17160897	CNVD
Cancer	21183584	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
WAGR syndrome	22470819	CNVD
Neurodevelopmental disorder	22521361	CNVD
Denys-drash syndrome	19566914	CNVD
Familial wilms tumor	19566914	CNVD
Frasier syndrome	19566914	CNVD
Non-small cell lung cancer	21829676	CNVD
WAGR syndrome	20603712	CNVD
Autism	17322880	CNVD
Renal cell carcinoma	18765545	CNVD
Breast cancer	21858162	CNVD
Cancer	20164920	CNVD
Breast cancer	16620391	CNVD
Ependymoma	20639864	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:700 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:33023000-33026800	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
2	chr11:33023200-33033400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
3	chr11:33024000-33032800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
4	chr11:33025800-33026800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
5	chr11:33025800-33029400	Enhancers	Primary T helper cells PMA-I stimulated	--
6	chr11:33026000-33028400	Enhancers	Primary T helper cells fromperipheralblood	blood
7	chr11:33026000-33028400	Enhancers	Primary T killer memory cells from peripheral blood	blood
8	chr11:33026200-33028000	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
9	chr11:33026200-33028400	Enhancers	Primary T helper naive cells from peripheral blood	blood
10	chr11:33026200-33028400	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
11	chr11:33026200-33028400	Enhancers	Primary T killer naive cells fromperipheralblood	blood
12	chr11:33026400-33027800	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
13	chr11:33026400-33028200	Enhancers	Primary T regulatory cells fromperipheralblood	blood
14	chr11:33026400-33028200	Enhancers	Dnd41	blood
15	chr11:33026600-33027200	Enhancers	NHEK	skin
16	chr11:33026600-33027600	Flanking Active TSS	Primary T cells from cord blood	blood
17	chr11:33026800-33027000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
18	chr11:33026800-33027000	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
19	chr11:33026800-33027200	Enhancers	iPS-15b Cell Line	embryonic stem cell
20	chr11:33026800-33027200	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
21	chr11:33026800-33027600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
22	chr11:33026800-33027800	Enhancers	Thymus	Thymus
23	chr11:33026800-33028200	Enhancers	Primary T cells fromperipheralblood	blood
24	chr11:33026800-33028400	Enhancers	Fetal Thymus	thymus
25	chr11:33027000-33027400	Flanking Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
26	chr11:33027200-33028800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
27	chr11:33027200-33032600	Weak transcription	NHEK	skin
28	chr11:33027600-33028400	Enhancers	Primary T cells from cord blood	blood
29	chr11:33027600-33032600	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
30	chr11:33027800-33032600	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
31	chr11:33027800-33032600	Weak transcription	Thymus	Thymus
32	chr11:33028000-33032400	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
33	chr11:33028200-33032200	Weak transcription	Dnd41	blood
34	chr11:33028200-33032600	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
35	chr11:33028400-33031600	Weak transcription	Primary T helper cells fromperipheralblood	blood
36	chr11:33028400-33032200	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
37	chr11:33028400-33032400	Weak transcription	Primary T cells from cord blood	blood
38	chr11:33028400-33032400	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
39	chr11:33028400-33032400	Weak transcription	Primary T killer memory cells from peripheral blood	blood
40	chr11:33028400-33032600	Weak transcription	Primary T helper naive cells from peripheral blood	blood
41	chr11:33028800-33032000	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
42	chr11:33029400-33029600	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
43	chr11:33031200-33032000	Weak transcription	Primary T helper cells PMA-I stimulated	--
44	chr11:33031600-33034400	Enhancers	Primary T helper cells fromperipheralblood	blood
45	chr11:33031800-33034200	Enhancers	Hela-S3	cervix
46	chr11:33032000-33034400	Enhancers	Primary T helper cells PMA-I stimulated	--
47	chr11:33032000-33034800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
48	chr11:33032200-33033400	Enhancers	Dnd41	blood
49	chr11:33032200-33034400	Enhancers	Primary T cells fromperipheralblood	blood
50	chr11:33032200-33034400	Enhancers	Primary T killer naive cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links